As. Tang et al., UTILIZATION OF A HUMAN INTESTINAL EPITHELIAL-CELL CULTURE SYSTEM (CACO-2) FOR EVALUATING CYTOPROTECTIVE AGENTS, Pharmaceutical research, 10(11), 1993, pp. 1620-1626
Human intestinal epithelial cells (Caco-2) were cultured as confluent
monolayers on polycarbonate membranes in Transwells for investigating
their applicability in evaluating the cytoprotective activity of sucra
lfate. The control experiments established a reproducible chemical met
hod (using 0.5 mM indomethacin in Hanks' balanced salt solution) for i
nducing damage to the Caco-2 cell monolayers. Damage was determined by
measuring changes in transepithelial electrical resistance (TEER). Tw
enty-day-old Caco-2 cell monolayers were significantly and reproducibl
y damaged (compared to buffer alone) (P < 0.001) by application of 0.5
mM indomethacin to the apical side for 1 hr. While sucralfate, at a 0
.5, 2, or 5 mg/mL concentration in the buffer, was shown not to revers
e (treat) the damage caused by indomethacin in this cellular model, it
was able to protect (prevent) the cells from indomethacin-induced dam
age (P < 0.001). We observed that indomethacin-induced damage to the C
aco-2 cell monolayers greatly affected the paracellular pathway since
the percentage transport of [H-3]methoxyinulin was significantly eleva
ted. In contrast, protection of the Caco-2 cells with 5 mg/mL sucralfa
te in the presence of the damaging agent resulted in transport of the
paracellular marker similar to that in the control (HBSS-treated) cell
monolayers. This direct cytoprotective effect was thus independent of
vascular factors at neutral pH and was observed to be dose dependent
(0.5 to 5 mg/mL) when sucralfate was applied to the cells in the prese
nce of the damaging agent. These findings, which are consistent with t
hose observed for sucralfate in vivo (Okabe et al., Digest. Dis. Sci.
28:1034-1042, 1983), demonstrate the feasibility of using Caco-2 cell
monolayers as an in vitro cell culture system which may serve to ident
ify and rapidly screen the cytoprotective activity of potential drugs
and their pharmaceutical formulations.